Analytic Review: Glucose Controversies in the ICU

Hyperglycemia is common in critical illness and has been associated with increased morbidity and mortality. An era of tight glucose control began when intensive insulin therapy was shown to improve outcomes in a single-center randomized trial. More recently, with the publication of additional studie...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Intensive Care Medicine 2011-05, Vol.26 (3), p.135-150
Main Authors: Honiden, Shyoko, Inzucchi, Silvio E.
Format: Article
Language:English
Subjects:
Blood Glucose
Critical Illness
Humans
Hyperglycemia - drug therapy
Hypoglycemia - drug therapy
Hypoglycemic Agents - adverse effects
Hypoglycemic Agents - therapeutic use
Insulin - adverse effects
Insulin - therapeutic use
Intensive Care Units
Risk Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1812-5aef9b797d6e3937d6da712186350d263f495f7af05d94214f2bbb5030261a7c3
cites cdi_FETCH-LOGICAL-c1812-5aef9b797d6e3937d6da712186350d263f495f7af05d94214f2bbb5030261a7c3
container_end_page 150
container_issue 3
container_start_page 135
container_title Journal of Intensive Care Medicine
container_volume 26
creator Honiden, Shyoko
Inzucchi, Silvio E.
description Hyperglycemia is common in critical illness and has been associated with increased morbidity and mortality. An era of tight glucose control began when intensive insulin therapy was shown to improve outcomes in a single-center randomized trial. More recently, with the publication of additional studies, questions have been raised regarding the efficacy and safety of intensive glycemic management. This article will review the biologic mechanisms that may help us understand why and how hyperglycemia and insulin are relevant in critical illness. We will then explore insights gleaned from available clinical trials. Finally, we will discuss specific areas of controversy that relate to the implementation of glycemic control in the intensive care unit, such as the ideal glucose target and the importance of hypoglycemia.
doi_str_mv 10.1177/0885066610387892
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_871964180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0885066610387892</sage_id><sourcerecordid>871964180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1812-5aef9b797d6e3937d6da712186350d263f495f7af05d94214f2bbb5030261a7c3</originalsourceid><addsrcrecordid>eNp1kE1Lw0AURQdRbK3uXUl2rqLzZjJf7krQWigIYtfDJHnRlDSpM0ml_96UVheCq7e4594Hh5BroHcASt1TrQWVUgLlWmnDTsgYBBMxJNqckvE-jvf5iFyEsKIUOONwTkYMALSWfExg2rh611V59IrbCr8eolnd523AKG2bzrdb9KHCEFVN1H1gNE-Xl-SsdHXAq-OdkOXT41v6HC9eZvN0uohz0MBi4bA0mTKqkMgNH07hFDAYvgpaMMnLxIhSuZKKwiQMkpJlWSYop0yCUzmfkNvD7sa3nz2Gzq6rkGNduwbbPlitwMgENB1IeiBz34bgsbQbX62d31mgdu_J_vU0VG6O4322xuK38CNmAOIDENw72lXb-8FT-H_wGxc3bOc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>871964180</pqid></control><display><type>article</type><title>Analytic Review: Glucose Controversies in the ICU</title><source>Sage Journals Online</source><creator>Honiden, Shyoko ; Inzucchi, Silvio E.</creator><creatorcontrib>Honiden, Shyoko ; Inzucchi, Silvio E.</creatorcontrib><description>Hyperglycemia is common in critical illness and has been associated with increased morbidity and mortality. An era of tight glucose control began when intensive insulin therapy was shown to improve outcomes in a single-center randomized trial. More recently, with the publication of additional studies, questions have been raised regarding the efficacy and safety of intensive glycemic management. This article will review the biologic mechanisms that may help us understand why and how hyperglycemia and insulin are relevant in critical illness. We will then explore insights gleaned from available clinical trials. Finally, we will discuss specific areas of controversy that relate to the implementation of glycemic control in the intensive care unit, such as the ideal glucose target and the importance of hypoglycemia.</description><identifier>ISSN: 0885-0666</identifier><identifier>EISSN: 1525-1489</identifier><identifier>DOI: 10.1177/0885066610387892</identifier><identifier>PMID: 21118863</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Blood Glucose ; Critical Illness ; Humans ; Hyperglycemia - drug therapy ; Hypoglycemia - drug therapy ; Hypoglycemic Agents - adverse effects ; Hypoglycemic Agents - therapeutic use ; Insulin - adverse effects ; Insulin - therapeutic use ; Intensive Care Units ; Risk Factors ; Treatment Outcome</subject><ispartof>Journal of Intensive Care Medicine, 2011-05, Vol.26 (3), p.135-150</ispartof><rights>2011 SAGE Publications</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1812-5aef9b797d6e3937d6da712186350d263f495f7af05d94214f2bbb5030261a7c3</citedby><cites>FETCH-LOGICAL-c1812-5aef9b797d6e3937d6da712186350d263f495f7af05d94214f2bbb5030261a7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,780,784,792,27922,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21118863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Honiden, Shyoko</creatorcontrib><creatorcontrib>Inzucchi, Silvio E.</creatorcontrib><title>Analytic Review: Glucose Controversies in the ICU</title><title>Journal of Intensive Care Medicine</title><addtitle>J Intensive Care Med</addtitle><description>Hyperglycemia is common in critical illness and has been associated with increased morbidity and mortality. An era of tight glucose control began when intensive insulin therapy was shown to improve outcomes in a single-center randomized trial. More recently, with the publication of additional studies, questions have been raised regarding the efficacy and safety of intensive glycemic management. This article will review the biologic mechanisms that may help us understand why and how hyperglycemia and insulin are relevant in critical illness. We will then explore insights gleaned from available clinical trials. Finally, we will discuss specific areas of controversy that relate to the implementation of glycemic control in the intensive care unit, such as the ideal glucose target and the importance of hypoglycemia.</description><subject>Blood Glucose</subject><subject>Critical Illness</subject><subject>Humans</subject><subject>Hyperglycemia - drug therapy</subject><subject>Hypoglycemia - drug therapy</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin - adverse effects</subject><subject>Insulin - therapeutic use</subject><subject>Intensive Care Units</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><issn>0885-0666</issn><issn>1525-1489</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp1kE1Lw0AURQdRbK3uXUl2rqLzZjJf7krQWigIYtfDJHnRlDSpM0ml_96UVheCq7e4594Hh5BroHcASt1TrQWVUgLlWmnDTsgYBBMxJNqckvE-jvf5iFyEsKIUOONwTkYMALSWfExg2rh611V59IrbCr8eolnd523AKG2bzrdb9KHCEFVN1H1gNE-Xl-SsdHXAq-OdkOXT41v6HC9eZvN0uohz0MBi4bA0mTKqkMgNH07hFDAYvgpaMMnLxIhSuZKKwiQMkpJlWSYop0yCUzmfkNvD7sa3nz2Gzq6rkGNduwbbPlitwMgENB1IeiBz34bgsbQbX62d31mgdu_J_vU0VG6O4322xuK38CNmAOIDENw72lXb-8FT-H_wGxc3bOc</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Honiden, Shyoko</creator><creator>Inzucchi, Silvio E.</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201105</creationdate><title>Analytic Review: Glucose Controversies in the ICU</title><author>Honiden, Shyoko ; Inzucchi, Silvio E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1812-5aef9b797d6e3937d6da712186350d263f495f7af05d94214f2bbb5030261a7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Blood Glucose</topic><topic>Critical Illness</topic><topic>Humans</topic><topic>Hyperglycemia - drug therapy</topic><topic>Hypoglycemia - drug therapy</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin - adverse effects</topic><topic>Insulin - therapeutic use</topic><topic>Intensive Care Units</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Honiden, Shyoko</creatorcontrib><creatorcontrib>Inzucchi, Silvio E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Intensive Care Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Honiden, Shyoko</au><au>Inzucchi, Silvio E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analytic Review: Glucose Controversies in the ICU</atitle><jtitle>Journal of Intensive Care Medicine</jtitle><addtitle>J Intensive Care Med</addtitle><date>2011-05</date><risdate>2011</risdate><volume>26</volume><issue>3</issue><spage>135</spage><epage>150</epage><pages>135-150</pages><issn>0885-0666</issn><eissn>1525-1489</eissn><abstract>Hyperglycemia is common in critical illness and has been associated with increased morbidity and mortality. An era of tight glucose control began when intensive insulin therapy was shown to improve outcomes in a single-center randomized trial. More recently, with the publication of additional studies, questions have been raised regarding the efficacy and safety of intensive glycemic management. This article will review the biologic mechanisms that may help us understand why and how hyperglycemia and insulin are relevant in critical illness. We will then explore insights gleaned from available clinical trials. Finally, we will discuss specific areas of controversy that relate to the implementation of glycemic control in the intensive care unit, such as the ideal glucose target and the importance of hypoglycemia.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>21118863</pmid><doi>10.1177/0885066610387892</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-0666
ispartof Journal of Intensive Care Medicine, 2011-05, Vol.26 (3), p.135-150
issn 0885-0666
1525-1489
language eng
recordid cdi_proquest_miscellaneous_871964180
source Sage Journals Online
subjects Blood Glucose
Critical Illness
Humans
Hyperglycemia - drug therapy
Hypoglycemia - drug therapy
Hypoglycemic Agents - adverse effects
Hypoglycemic Agents - therapeutic use
Insulin - adverse effects
Insulin - therapeutic use
Intensive Care Units
Risk Factors
Treatment Outcome
title Analytic Review: Glucose Controversies in the ICU
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A55%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analytic%20Review:%20Glucose%20Controversies%20in%20the%20ICU&rft.jtitle=Journal%20of%20Intensive%20Care%20Medicine&rft.au=Honiden,%20Shyoko&rft.date=2011-05&rft.volume=26&rft.issue=3&rft.spage=135&rft.epage=150&rft.pages=135-150&rft.issn=0885-0666&rft.eissn=1525-1489&rft_id=info:doi/10.1177/0885066610387892&rft_dat=%3Cproquest_cross%3E871964180%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1812-5aef9b797d6e3937d6da712186350d263f495f7af05d94214f2bbb5030261a7c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=871964180&rft_id=info:pmid/21118863&rft_sage_id=10.1177_0885066610387892&rfr_iscdi=true